𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

✍ Scribed by S. Iino; J. Toyota; H. Kumada; K. Kiyosawa; S. Kakumu; M. Sata; H. Suzuki; E. B. Martins

Book ID
108885796
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
120 KB
Volume
12
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of thymosin Ξ±1 in patients with
Efficacy of thymosin Ξ±1 in patients with chronic hepatitis B: A randomized, controlled trial
✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T

A randomized controlled trial of thymosi
A randomized controlled trial of thymosin-Ξ±1 versus interferon alfa treatment in patients with hepatitis B e antigen antibodyβ€”and hepatitis B virus DNAβ€”positive chronic hepatitis B
✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission